Thomas Heathman

Striving to make cell and gene therapy products accessible to patients in need

[Thomas Heathman @Thomas_Heathman]

This is LITERALLY why we do what we do. Please help the Opie Jones Foundation in their mission to support families devastated by cancer.

We NEED to see more smiles like this in the world 😄 ❤️ https://t.co/n7Sreeb4QZ

[Thomas Heathman @Thomas_Heathman]

Very interesting take on "Flexibility" from Cell & Gene. We are in an industry where we are expected to consistently manufacture high quality products with a highly variable, patient-specific input. Flexibility in manufacturing technology is one of the ke…https://t.co/9IWC8EYEdi

[Thomas Heathman @Thomas_Heathman]

Support is available for anyone going through a tough time following a cancer diagnosis. The Opie Jones Foundation is doing amazing work to support families in need who feel like they have no one else to turn to.

https://t.co/oNd7s2PqrH

#mentalhealthaw…https://t.co/K7Q4hm2Nam

[Thomas Heathman @Thomas_Heathman]

Wow - 1,000 citations!

Can I be honest? It is extremely frustrating that the first paper I wrote, "The translation of cell-based therapies: clinical landscape and manufacturing challenges" still has a lot of relevance 10 years later...

Significant Pro…https://t.co/BIuJB4QjCl

[Thomas Heathman @Thomas_Heathman]

What an amazing week we spent with the Ori team to kick off 2023!

The commercial team had a chance to get together (in person!) to reflect on our successes in 2022 and forge a path ahead for 2023.

💭 I kept thinking “Wow! What an amazing team I am a pa…https://t.co/RE0tXLMFPd

[Thomas Heathman @Thomas_Heathman]

Free Solo… @ El Capitan https://t.co/OomwFgTc8R

[Thomas Heathman @Thomas_Heathman]

Beyond excited to partner with such an incredible organization and work with amazing people like Jason Bock, Kimiya, Houman and the team at CTMC / A joint venture between Resilience + MD Anderson Cancer Center.

We share a mission to enable widespread ac…https://t.co/Z32HVkU3Ar

[Oribiotech @OriBiotech]

Thanks @somXhealthtech & @googlecloud for last night's #healthtechtalks event, talking all things biotech!

@Ori_JCFoster joined @Joanna_Holbrook & @JamesSomauroo for a wide-ranging discussion on:
🔹Biotech vs techbio
🔹The importance of crafting a story
🔹Why paper is the enemy

[Thomas Heathman @Thomas_Heathman]

Great start to Onco Cell Therapy Series in Boston with John Langowski from Kite Pharma discussing next-gen approaches for LBCL "We need to develop next gen LBCL treatments to deepen clinical responses"

My Key Takeaways:
1. Demonstration of correlation be…https://t.co/9BGcASrfn7

[Thomas Heathman @Thomas_Heathman]

Will you be at the Onco Cell Therapy Summit (OCTS) this week in Boston?

Send me a message and we can set up some time to chat! #celltherapy #OCTS https://t.co/85HWWQKwZd

[Thomas Heathman @Thomas_Heathman]

Ori is officially a "Soonicorn" - Named by Sifted in the top 100 of Europe's future Unicorns! Ori representing for the Healthtech industry :) https://t.co/vbBPEFDMBx

[Thomas Heathman @Thomas_Heathman]

Great to sit down with Sarah and RegMedNet to discuss the challenges of patient access in #cellandgenetherapy and how at Ori we are generating unique solutions at the intersection of #biology, #engineering and #data! https://t.co/v60iEnYPzV

[Thomas Heathman @Thomas_Heathman]

Never has someone been more deserving of a career achievement award. Thank you Robert Preti for everything you have done for our industry! https://t.co/G61hL27d6c

[Oribiotech @OriBiotech]

This week the Ori team - old and new - came together to connect, refocus on our values & create future plans.

We left feeling inspired & excited to put our plans into action...joining advocates like the @EWhiteheadFdn on our mission to increase patient access to CAR-T therapies.

[Thomas Heathman @Thomas_Heathman]

Great to finally be back at Phacilitate for Advanced Therapies week! If you want to find out a bit more about Ori Biotech or just have a catch up let me know, I’m here all week! #cellandgenetherapy #advancedtherapiesweek #innovation https://t.co/ipjn1WJAHb

[Thomas Heathman @Thomas_Heathman]

I am delighted to share that we have raised over $100M in an oversubscribed Series B! A big thank you to all of our investors and partners that made this possible.

Our team at Ori is on a mission to enable widespread access to ce…https://t.co/CW0CqpMN1c https://t.co/tjslrWJYs0

[Thomas Heathman @Thomas_Heathman]

Hello Network! I will be attending Phacilitate Advanced Therapies Week in Miami, alongside the Ori Biotech team. Please reach out if you're attending - I'd love to catch up! ☕️ #advancedtherapies #celltherapy #genetherapy #biotech #team https://t.co/FEmgWReNHy

[Oribiotech @OriBiotech]

Yesterday we hosted our second ever in-person team meeting - and we were lucky enough to finally be joined by our US colleagues!

Great to spend time reconnecting on our common purpose and laser-focussing in on how we our vision of widespread access to life-changing therapies.

[Thomas Heathman @Thomas_Heathman]

@OriBiotech Awesome to be there and see everyone!!! Feel so lucky to have such amazing colleagues 😊

[Thomas Heathman @Thomas_Heathman]

Associate Scientist role open in our London, UK labs! https://t.co/g99D2VWg0e